... II clinical trial of Puma's drug neratinib at the 2019 San Antonio Breast Cancer Symposium (SABCS) that is currently taking place in San Antonio, Texas. ... A full copy of the poster is available on the Puma Biotechnology website.
News
- Puma Biotech (PBYI) Highlights Interim Results of Phase II CONTROL Trial of Neratinib in ...
- Stocks rise on Wall Street as rally stretches to fourth day
... slumped 10.5% for the biggest loss in the S&P 500 after after it said it's merging with DuPont's Nutrition and Biosciences unit in a $26.2 billion deal.
- Global Sepsis Diagnostics Market, Top key players Mitsubishi Chemical, EKF Diagnostics ...
... Sepsis Diagnostics Market, Top key players Mitsubishi Chemical, EKF Diagnostics, Cytosorbents, Response Biomedical, .... 1604 W San Antonio,.
- ORIC Pharmaceuticals Presents Preclinical Data on Glucocorticoid Receptor Antagonist at 2019 ...
... with nab-paclitaxel in patients with advanced solid tumors, at the 2019 San Antonio Breast Cancer Symposium. ... ORIC is funded by leading biotechnology investors and is headquartered in South San Francisco, California.
- IFF to merge with DuPont Nutrition and Biosciences unit
NEW YORK (AP) — International Flavors and Fragrances is merging with DuPont's Nutrition and Biosciences unit in a $26.2 billion deal that would ...